Lyell Immunopharma, Inc. — All Filings
300 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001808821-26-000006 | Mar 16, 2026 | Mar 9, 2026 |
| 3 | — | 0001808821-26-000005 | Mar 16, 2026 | Mar 9, 2026 |
| S-8 | S-8 | 0001193125-26-104336 | Mar 12, 2026 | — |
| 10-K | 10-K | 0001628280-26-017253 | Mar 12, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-017244 | Mar 12, 2026 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000234 | Mar 9, 2026 | Mar 6, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000235 | Mar 9, 2026 | Mar 6, 2026 |
| 8-K | 8-K | 0001193125-26-097615 | Mar 9, 2026 | Mar 6, 2026 |
| 4 | — | 0001327111-26-000002 | Feb 12, 2026 | Feb 11, 2026 |
| 4 | — | 0001907345-26-000002 | Feb 12, 2026 | Feb 11, 2026 |
| 4 | — | 0001866154-26-000002 | Feb 12, 2026 | Feb 11, 2026 |
| 4 | — | 0001327111-26-000001 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | — | 0001907345-26-000001 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | — | 0001771329-26-000001 | Feb 11, 2026 | Feb 10, 2026 |
| 4 | — | 0002095702-26-000002 | Feb 11, 2026 | Feb 10, 2026 |
| 4 | — | 0001866154-26-000001 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | — | 0001959742-26-000001 | Feb 11, 2026 | Feb 10, 2026 |
| 4 | — | 0002095702-26-000001 | Jan 6, 2026 | Dec 24, 2025 |
| 424B5 | 424B5 | 0001193125-25-324801 | Dec 18, 2025 | — |
| EFFECT | — | 9999999995-25-003741 | Dec 15, 2025 | — |
| 8-K | 8-K | 0001193125-25-310469 | Dec 8, 2025 | Dec 7, 2025 |
| S-3 | S-3 | 0001193125-25-309779 | Dec 5, 2025 | — |
| 8-K | 8-K | 0001193125-25-309621 | Dec 5, 2025 | Dec 3, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-112479 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001012975-25-000768 | Nov 14, 2025 | — |
| SCHEDULE 13G | — | 0001140361-25-042006 | Nov 13, 2025 | — |
| 4 | — | 0001866154-25-000006 | Nov 12, 2025 | Nov 10, 2025 |
| 4 | — | 0001907345-25-000006 | Nov 12, 2025 | Nov 10, 2025 |
| 4 | — | 0002095702-25-000003 | Nov 12, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | — | 0001193125-25-277861 | Nov 12, 2025 | — |
| 4 | — | 0001327111-25-000007 | Nov 12, 2025 | Nov 10, 2025 |
| 8-K | 8-K | 0001628280-25-051603 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-051619 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-273269 | Nov 10, 2025 | Nov 6, 2025 |
| 3 | — | 0002095702-25-000002 | Nov 10, 2025 | Oct 31, 2025 |
| 8-K | 8-K | 0001193125-25-261753 | Nov 3, 2025 | Oct 31, 2025 |
| 4 | — | 0001866154-25-000005 | Oct 29, 2025 | Oct 27, 2025 |
| 4 | — | 0001907345-25-000005 | Oct 29, 2025 | Oct 27, 2025 |
| 4 | — | 0001327111-25-000006 | Oct 29, 2025 | Oct 27, 2025 |
| 8-K | 8-K | 0001193125-25-205020 | Sep 16, 2025 | Sep 15, 2025 |
| 4 | — | 0001415889-25-022746 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022740 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022747 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022741 | Aug 22, 2025 | Aug 20, 2025 |
| SCHEDULE 13G | — | 0001415889-25-022288 | Aug 19, 2025 | — |
| EFFECT | — | 9999999995-25-002652 | Aug 15, 2025 | — |
| 4 | — | 0001415889-25-021691 | Aug 13, 2025 | Aug 11, 2025 |
| 4 | — | 0001415889-25-021692 | Aug 13, 2025 | Aug 11, 2025 |
| 4 | — | 0001415889-25-021693 | Aug 13, 2025 | Aug 11, 2025 |
| 4 | — | 0001415889-25-021694 | Aug 13, 2025 | Aug 11, 2025 |